SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in the 2019 Wells Fargo Healthcare Conference in Boston, MA.  Dr. Helen Torley, president and chief executive officer,

HOUSTON, Aug. 26, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has engaged argodesign, an award-winning

AUSTIN, Texas, Aug. 26, 2019 /PRNewswire/ -- Leading health and wellness solutions provider, Salutoceuticals, LLC, announced the launch of their new Sleep Remedy formula designed for more effectiveness and efficiency.

WOODCLIFF LAKE, N.J., Aug. 26, 2019 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Priya Chaturvedi, Ph.D., as Vice President, Global Clinical Quality Assurance.

SHELTON, Conn., Aug. 26, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that it has filed its annual report (Form 10-K) for the financial year ending June 30, 2019, with the Securities and Exchange Commission (SEC) on Friday, August 23, 2019. The report can be acce

WELLESLEY, Mass., Aug. 26, 2019 /PRNewswire/ -- 4G Clinical today announced its recognition as a finalist in the 2019 European Innovations Awards for its cutting-edge approach to cohort management within its

TOKYO, Aug. 26, 2019 /PRNewswire/ -- Atonarp, a hi-tech molecular diagnostics company, today announced that it has raised $33 million in an oversubscribed Series C funding round. This financing round has attracted five new investors including Japan Post Investment Corporation, SBI Investment Co., Ltd, and Northwestern Mutual Future Ventures as well as curr

BERLIN, Aug. 26, 2019 /PRNewswire/ -- At EUROISMAR 2019 (https://conference.euroismar2019.org), Bruker Corporation (Nasdaq: BRKR) today announce

Lock-up includes founders, early shareholders and other key stakeholders and represents approximately 47% of outstanding shares (common equivalents) VANCOUVER, British Columbia and PHOENIX, Aug. 26, 2019 /PRNewswire/ -- 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company

SAN JOSE, Calif., Aug. 26, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today anno